These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30687468)

  • 1. Clinical features of drug-induced Parkinsonism.
    Shiraiwa N; Tamaoka A; Ohkoshi N
    Neurol Int; 2018 Dec; 10(4):7877. PubMed ID: 30687468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency and clinical profile of Parkinson's disease and other Parkinsonian syndromes seen in the Department of Neurology at the Befelatanana Hospital Antananarivo].
    Rasaholiarison NF; Razafimahefa J; Rakotomanana JL; Tehindrazanarivelo AD
    Pan Afr Med J; 2019; 33():229. PubMed ID: 31692664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced parkinsonism in a movement disorders unit: A four-year survey.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Ayuso-Peralta L; Gasalla T; Cabrera-Valdivia F; Vaquero A; Tejeiro J; García-Albea E
    Parkinsonism Relat Disord; 1996 Jul; 2(3):145-9. PubMed ID: 18591033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria.
    Okubadejo NU; Ojo OO; Oshinaike OO
    BMC Neurol; 2010 Jan; 10():1. PubMed ID: 20051133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia in Parkinsonism: Prevalence, Predictors and Correlation with Severity of Illness Fasting).
    Shilimkar Y; Londhe C; Sundar U; Darole P
    J Assoc Physicians India; 2020 May; 68(5):22-25. PubMed ID: 32610861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study.
    Wei CY; Tzeng IS; Lin MC; Yeh YH; Hsu CY; Kung WM
    Front Pharmacol; 2020; 11():433. PubMed ID: 32390831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
    Imai N; Ikawa M
    Intern Med; 2011; 50(6):635-7. PubMed ID: 21422693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autosomal recessive early-onset parkinsonism with diurnal fluctuation (AR-EPDF)--clinical characteristics].
    Yamamura Y; Kohriyama T; Kawakami H; Kaseda Y; Kuzuhara S; Nakamura S
    Rinsho Shinkeigaku; 1996 Aug; 36(8):944-50. PubMed ID: 8958746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced parkinsonism.
    Mena MA; de Yébenes JG
    Expert Opin Drug Saf; 2006 Nov; 5(6):759-71. PubMed ID: 17044803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.
    Takubo H; Harada T; Hashimoto T; Inaba Y; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S31-41. PubMed ID: 12735913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis.
    Kasamo S; Takeuchi M; Ikuno M; Kawasaki Y; Tanaka S; Takahashi R; Kawakami K
    J Neurol; 2019 Aug; 266(8):1944-1952. PubMed ID: 31076875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimetazidine and parkinsonism: A prospective study.
    Pintér D; Kovács M; Harmat M; Juhász A; Janszky J; Kovács N
    Parkinsonism Relat Disord; 2019 May; 62():117-121. PubMed ID: 30638818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
    Silver M; Factor SA
    Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of recognition of drug-induced parkinsonism in the elderly.
    Esper CD; Factor SA
    Mov Disord; 2008 Feb; 23(3):401-4. PubMed ID: 18067180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of parkinsonism and Parkinson's disease.
    Camicioli R
    Drugs Today (Barc); 2002 Oct; 38(10):677-86. PubMed ID: 12582453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.